NARA Discovery
Article Details
← Back to Search Results
Journal Article

Circulating concentrations of free triiodothyronine are associated with central adiposity and cardiometabolic risk factors in young euthyroid adults

Elisa Merchan-Ramirez; Guillermo Sanchez-Delgado; Cristina Arrizabalaga-Arriazu; Francisco M Acosta; Maria Jose Arias-Tellez; Manuel Muñoz-Torres; Jose V Garcia-Lario; Jose M Llamas-Elvira; Jonatan R Ruiz
Journal of Physiology and Biochemistry · Vol. 78, Issue 3 · pp. 629-640 · 2022

Abstract

Thyroid dysfunction is associated with classic cardiometabolic risk factors in humans. However, this relationship remains unclear in young euthyroid adults. The present work examines the associations of circulating thyroid hormones (THs) and thyroid-stimulating hormone (TSH) concentrations with body composition and cardiometabolic risk factors in young euthyroid adults. A total of 106 sedentary, euthyroid adults (72 women; 22 ± 2 years old) participated in this cross-sectional study. THs and TSH serum concentrations were determined in fasting conditions (6 h). Body composition (fat mass (FM), lean mass (LM), and visceral adipose tissue (VAT)) was determined by dual-energy X-ray absorptiometry, anthropometric parameters (weight, height, and waist circumference) were measured, and neck adipose tissue mass was quantified through computed tomography (CT) scanning. Cardiometabolic risk factors including fasting glucose and lipid metabolism markers, hepatic phosphatase and transaminases, and blood pressure were also assessed. Free triiodothyronine (FT3) concentration was positively associated with body mass index, LM, VAT, and waist circumference (all P ≤ 0.038). FT3 was also associated with glucose, insulin, HOMA-IR, fatty liver index, and blood pressure (all P < 0.024). All the associations were attenuated when adjusting for sex. In contrast, we found no associations of TSH or free thyroxine with any body composition parameter or cardiometabolic risk factors. In conclusion, FT3 is associated with central adiposity and cardiometabolic risk factors including insulin resistance, fatty liver index, and mean, systolic and diastolic blood pressure in young euthyroid adults. ClinicalTrials.gov identifier: NCT02365129.

Bibliographic Information

JournalJournal of Physiology and Biochemistry
PublisherSpringer
Publication Date2022-08-01
Publication Year2022
Volume78
Issue3
Pages629-640
Document TypeJournal Article
Print ISSN1138-7548
eISSN1877-8755
DOI10.1007/s13105-022-00881-w

Access Information

NARA Access Coverage1998-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13105
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.